JPY 1669.0
(-2.51%)
Breakdown | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenue | 2.76 Billion | 2.77 Billion | 1.97 Billion | 1.25 Billion |
Cost of Revenue | 921.95 Million | 1.04 Billion | 796.36 Million | 678.01 Million |
Gross Profit | 1.84 Billion | 1.72 Billion | 1.18 Billion | 581.3 Million |
Operating Expenses | 1.55 Billion | 1.32 Billion | 1.34 Billion | 846.15 Million |
Selling, General and Administrative Expenses | 1.55 Billion | 1.32 Billion | 1.34 Billion | 846 Million |
Research and Development Expenses | - | 10 Million | 10.26 Million | 25.36 Million |
Other Expenses | - | 3.81 Million | 5.38 Million | 6.18 Million |
Cost and Expenses | 2.47 Billion | 2.37 Billion | 2.14 Billion | 1.52 Billion |
Operating Income | 290.34 Million | 402.78 Million | -163.5 Million | -264.85 Million |
Interest Expense | 293 Thousand | 319 Thousand | 320 Thousand | 319 Thousand |
Income Tax Expense | 67.95 Million | 41.84 Million | 2.29 Million | 2.29 Million |
Earnings before Tax | 286.67 Million | 379.75 Million | -194.07 Million | -348.13 Million |
Net Income | 218.71 Million | 421.59 Million | -196.36 Million | -350.42 Million |
Earnings Per Share Basic | 24.30 | 53.41 | -41.18 | -41.66 |
Earnings Per Share Diluted | 21.04 | 43.43 | -41.18 | -41.66 |
Weighted Average Shares Outstanding | 9 Million | 7.89 Million | 4.76 Million | 8.41 Million |
Weighted Average Shares Outstanding (Diluted) | 10.39 Million | 9.7 Million | 4.76 Million | 8.41 Million |
Gross Margin | 0.67 | 0.62 | 0.60 | 0.46 |
EBIT Margin | 0.11 | 0.14 | -0.09 | -0.21 |
Profit Margin | 0.08 | 0.15 | -0.10 | -0.28 |
EBITDA | 292.77 Million | 380.18 Million | -193.75 Million | -347.81 Million |
Earnings Before Tax Margin | 0.10 | 0.15 | -0.08 | -0.21 |
Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
---|---|---|---|---|---|---|
Revenue | 720.85 Million | 620.72 Million | 771.3 Million | 653.37 Million | 674.66 Million | 2.77 Billion |
Cost of Revenue | 230.1 Million | 209.46 Million | 250.22 Million | 233.83 Million | 235.26 Million | 1.04 Billion |
Gross Profit | 490.74 Million | 411.26 Million | 521.07 Million | 419.53 Million | 439.4 Million | 1.72 Billion |
Operating Expenses | 391.88 Million | 422.02 Million | 375.58 Million | 362.78 Million | 415.44 Million | 1.32 Billion |
Selling, General and Administrative Expenses | 391.88 Million | 412.93 Million | 376 Million | 362 Million | 415 Million | - |
Research and Development Expenses | - | 9.08 Million | 11.38 Million | 3.93 Million | 10 Million | - |
Other Expenses | - | -3.39 Million | 489 Thousand | 609 Thousand | 6.59 Million | 3.81 Million |
Cost and Expenses | 621.99 Million | 631.49 Million | 625.8 Million | 596.61 Million | 650.71 Million | 2.37 Billion |
Operating Income | 98.85 Million | -10.76 Million | 145.49 Million | 56.75 Million | 23.95 Million | 402.78 Million |
Interest Expense | 53 Thousand | 81 Thousand | 80 Thousand | 79 Thousand | 80 Thousand | 319 Thousand |
Income Tax Expense | 33.35 Million | 2.85 Million | 22.52 Million | 9.22 Million | 40.12 Million | 41.84 Million |
Earnings before Tax | 98.89 Million | -14.35 Million | 145.22 Million | 56.91 Million | 3.92 Million | 379.75 Million |
Net Income | 65.53 Million | -17.21 Million | 122.7 Million | 47.69 Million | 47.48 Million | 421.59 Million |
Earnings Per Share Basic | 7.14 | -1.88 | 13.72 | 5.51 | 5.57 | - |
Earnings Per Share Diluted | 7.14 | -1.88 | 11.71 | 4.59 | 3.00 | - |
Weighted Average Shares Outstanding | 9.18 Million | 9.15 Million | 10.5 Million | 8.65 Million | 15.64 Million | 7.89 Million |
Weighted Average Shares Outstanding (Diluted) | 9.18 Million | 9.15 Million | 10.5 Million | 10.39 Million | 15.64 Million | 9.7 Million |
Gross Margin | 0.68 | 0.66 | 0.68 | 0.64 | 0.65 | 0.62 |
EBIT Margin | 0.14 | -0.01 | 0.19 | 0.09 | 0.01 | - |
Profit Margin | 0.09 | -0.03 | 0.16 | 0.07 | 0.07 | 0.15 |
EBITDA | 101.71 Million | -9.08 Million | 145.3 Million | 56.99 Million | 4 Million | - |
Earnings Before Tax Margin | 0.14 | -0.02 | 0.19 | 0.09 | 0.04 | 0.15 |
KESORAMIND
0012
SLFPY
CENTEXT
ELYM
PHIL